India Proposes Risk-Based Pre-Inspections Among Fixes to Address Substandard Drugs

Drug Industry Daily
India’s Ministry of Health is proposing that drug regulators and drugmakers implement several measures to improve the quality of drugs in the country’s supply chain, following a government estimate that 10 percent of them are substandard.

To View This Article:


Subscribe To Drug Industry Daily